Sort   by:  
 Page size 
UnknownPD-1 and PD-L1 antibodies for melanoma.
Not available
S-EPMC4514131 | biostudies-literature
UnknownPhase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.
Not available
S-EPMC3251861 | biostudies-literature
UnknownPhase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Not available
S-EPMC2645111 | biostudies-literature
UnknownProgrammed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.
Not available
S-EPMC5562434 | biostudies-literature
UnknownPhase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies.
Not available
S-EPMC3972922 | biostudies-literature
UnknownIntratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.
Not available
S-EPMC9868004 | biostudies-literature
UnknownLong-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma.
Not available
S-EPMC8388128 | biostudies-literature
UnknownDiscovering dominant tumor immune archetypes in a pan-cancer census.
Not available
S-EPMC8862608 | biostudies-literature
UnknownA prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793 | biostudies-literature
UnknownThe African Critical Illness Outcomes Study (ACIOS): a point prevalence study of critical illness in 22 nations in Africa.
Not available
S-EPMC11872788 | biostudies-literature
Sort   by:  
 Page size